{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:30:51Z","timestamp":1775831451390,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1016\/s0021-9150(97)00192-5","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:25:06Z","timestamp":1027657506000},"page":"125-131","source":"Crossref","is-referenced-by-count":42,"title":["Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit"],"prefix":"10.1016","volume":"136","author":[{"given":"Sianna","family":"Panagiotopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bucala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mark E. Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Jerums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0021-9150(97)00192-5_BIB1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","article-title":"Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure","volume":"343","author":"Makita","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB3","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.3487117","article-title":"Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking","volume":"232","author":"Brownlee","year":"1986","journal-title":"Science"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB4","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.91.16.7742","article-title":"Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications","volume":"91","author":"Wautier","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI114366","article-title":"Macrophage\/monocyte receptor for nonenzymatic glycosylated proteins is upregulated by cachectin\/tumor necrosis factor","volume":"84","author":"Vlassara","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1172\/JCI109950","article-title":"Glycosylation of human collagen in aging and diabetes mellitus","volume":"66","author":"Schnider","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.170.4.1387","article-title":"Endothelial receptor mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties","volume":"170","author":"Esposito","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1172\/JCI115928","article-title":"Advanced glycosylation endproducts block the anti-proliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus","volume":"90","author":"Hogan","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0168-8227(92)90129-F","article-title":"Secretion of a chemotactic substance(s) by AGE stimulated human monocytes","volume":"16","author":"Gilcrease","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB10","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.87.22.9010","article-title":"Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging","volume":"87","author":"Kirstein","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03401582","article-title":"Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits","volume":"1","author":"Vlassara","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice\u2014a potential mechanism for the accelerated vasculopathy of diabetes","volume":"96","author":"Schmidt","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/diabetes.34.9.938","article-title":"Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein","volume":"34","author":"Brownlee","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB14","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","article-title":"Lipid advanced glycosylation: pathway for lipid oxidation in vivo","volume":"90","author":"Bucala","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0021-9150(93)90084-8","article-title":"Glycosylation of LDL is more sensitive to oxidation: Implications for the diabetic patient","volume":"102","author":"Bowie","year":"1993","journal-title":"Atherosclerosis"},{"issue":"supp 2","key":"10.1016\/S0021-9150(97)00192-5_BIB16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/diab.41.2.S67","article-title":"Lipoprotein glycation and its metabolic consequences","volume":"41","author":"Lyons","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB17","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2337\/diabetes.37.12.1652","article-title":"Enhancement of platelet aggregation by low density lipoproteins from IDDM patients","volume":"37","author":"Watanabe","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB18","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(93)90142-Y","article-title":"Glycation and oxidation: a role in the pathogenesis of atherosclerosis","volume":"71","author":"Lyons","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB19","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","article-title":"Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy","volume":"88","author":"Hammes","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/diabetes.40.10.1328","article-title":"Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat","volume":"40","author":"Soulis-Liparota","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/diabetes.41.1.47","article-title":"Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats","volume":"41","author":"Kagihashi","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB22","first-page":"489","article-title":"The distribution and composition of serum lipoproteins in eighteen animals","volume":"40B","author":"Mills","year":"1971","journal-title":"Comp Biochem Physiol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB23","first-page":"236","article-title":"Lipid peroxide formation in microsomes","volume":"113","author":"Wills","year":"1969","journal-title":"Biochem J"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB24","first-page":"14","article-title":"A specific and sensitive assay for aminoguanidine: Its application to a study of the disposition of aminoguanidine in animal tissues","volume":"165","author":"Beavan","year":"1969","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/clinchem\/31.2.217","article-title":"Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol","volume":"31","author":"Warnick","year":"1985","journal-title":"Clin Chem"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB26","first-page":"42","article-title":"Technics for studying atherosclerotic lesions","volume":"7","author":"Holman","year":"1958","journal-title":"Lab Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB27","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/S0021-9258(18)42741-X","article-title":"Immunochemical detection of advanced glycosylation end products in vivo","volume":"267","author":"Makita","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005344-199202000-00013","article-title":"Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits","volume":"19","author":"Zhu","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0021-9150(94)90080-9","article-title":"Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture","volume":"106","author":"Fennessy","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110384","article-title":"Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine","volume":"68","author":"Henry","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB31","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1073\/pnas.89.24.12043","article-title":"Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications","volume":"89","author":"Vlassara","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB32","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.91.24.11704","article-title":"Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats","volume":"91","author":"Vlassara","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00428771","article-title":"Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin diabetic rats","volume":"37","author":"Huijberts","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00428774","article-title":"Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat","volume":"37","author":"Hammes","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1172\/JCI116716","article-title":"Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats","volume":"92","author":"Huijberts","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0021-9150(95)05526-3","article-title":"Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques","volume":"116","author":"Sakata","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0021-9150(93)90131-D","article-title":"Collagen linked fluorescence in human atherosclerotic plaques","volume":"98","author":"Lee","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.15.5.571","article-title":"Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB39","first-page":"1649","article-title":"Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus","volume":"143","author":"Nakamura","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB40","first-page":"654","article-title":"Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody","volume":"147","author":"Kume","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB41","first-page":"688","article-title":"Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease","volume":"146","author":"Ritthaler","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0021-9150(92)90260-N","article-title":"Non-enzymatic glycation of apolipoprotein B in sera of diabetic and non-diabetic subjects","volume":"93","author":"Tames","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/diabetes.31.4.283","article-title":"Nonenzymatic glycosylation of low-density lipoprotein alters its biological activity","volume":"31","author":"Witzum","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB44","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","article-title":"Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency","volume":"91","author":"Bucala","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj2560205","article-title":"Hydroxyl radical production and autoxidative glycosylation","volume":"256","author":"Hunt","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB46","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB47","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0022-2275(20)37921-9","article-title":"Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid","volume":"24","author":"Morel","year":"1983","journal-title":"J Lipid Res"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB48","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","article-title":"Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids","volume":"81","author":"Steinbrecher","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00410275","article-title":"The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague Dawley rat","volume":"38","author":"Soulis-Liparota","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB50","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.RES.77.3.536","article-title":"Evidence that expression of inducible nitric oxide synthase in response to endotoxin is augmented in atherosclerotic rabbits","volume":"77","author":"Sobey","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2337\/diabetes.41.4.552","article-title":"Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction","volume":"41","author":"Corbett","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00005344-199305000-00023","article-title":"Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits","volume":"21","author":"Verbeuren","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB53","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI115937","article-title":"Antiatherogenic effects of L-arginine in the hypercholesterolaemic rabbit","volume":"90","author":"Cooke","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.ATV.14.5.753","article-title":"Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits","volume":"14","author":"Cayatte","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0021-9150(97)00192-5_BIB55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI115014","article-title":"Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes","volume":"87","author":"Bucala","year":"1991","journal-title":"J Clin Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915097001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915097001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T02:41:15Z","timestamp":1621046475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915097001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S0021915097001925"],"URL":"https:\/\/doi.org\/10.1016\/s0021-9150(97)00192-5","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}